Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells

Journal of Immunology

Volumn 167, Issue 6, 2001, Pages 3316-3323

  Prebeck, S ^a   Kirschning, C ^a   Durr S ^a   Da Costa, C ^a   Donath, B ^a   Brand, K ^a   Redecke, V ^a   Wagner, H ^a   Miethke, T ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL INCLUSION; CELL STIMULATION; CELLULAR IMMUNITY; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 0035885168     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.6.3316     Document Type: Article

References (63)

1. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
2. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes
3. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line
4. Chlamydia pneumoniae infection in human monocytes
5. Chlamydia pneumoniae (TWAR)
6. Architecture of the cell envelope of Chlamydia psittaci 6BC
7. Comparative genomes of Chlamydia pneumoniae and C. trachomatis
8. Muramic acid is not detectable in Chlamydia psittaci or Chlamydia trachomatis by gas chromatography-mass spectrometry
9. Presence of muramic acid in Chlamydia trachomatis proved by liquid chromatography-mass spectrometry
10. Structural analysis of the lipopolysaccharide from Chlamydia trachomatis serotype L2
11. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification
12. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated
13. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response
14. Distribution of endosomal, lysosomal, and major histocompatability complex markers in a monocytic cell line infected with Chlamydia psittaci
15. Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells
16. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice
17. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses
18. The dendritic cell system and its role in immunogenicity
19. The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro
20. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
21. Innate immunity: The virtues of a nonclonal system of recognition
22. The mannose receptor is a pattern recognition receptor involved in host defense
23. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components
24. A Toll-like receptor recognizes bacterial DNA
25. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults
26. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense
27. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation
28. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
29. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
30. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
31. Immune cell activation by bacterial CpG-DNA through MyD88 and TRAF6
32. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2
33. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products
34. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors
35. Genetic control of susceptibility to Salmonella typhimurium in mice: Role of the LPS gene
36. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection
37. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways
38. The human Toll signaling pathway: Divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6. (TRAF6)
39. Unresponsiveness of MyD88-deficient mice to endotoxin
40. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades
41. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae
42. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
43. 4-Hydroxynonenal prevents NF-κB activation and tumor necrosis factor expression by inhibiting IκB phosphorylation and subsequent proteolysis
44. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide
45. Cutting edge: Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin
46. Function and activation of NF-κB in the immune system
47. MyD88, an adapter protein involved in interleukin-1 signaling
48. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
49. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro
50. Reactivation of persistent Chlamydia trachomatis infection in cell culture
51. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with γ interferon and tumor necrosis factor α
52. Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells
53. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ: Role of tryptophan catabolism
54. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase
55. Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid
56. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression
57. Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide
58. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
59. Endotoxin-tolerant mice have mutations in Toll-like receptor 4. (Tlr4)
60. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis
61. Chlamydia inhibits interferon γ-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1
62. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae
63. Chlamydia infections and heart disease linked through antigenic mimicry